A phase II study of CPT-11, a new derivative of camptothecin, for previously untreated non-small-cell lung cancer.

Fukuoka, M

A phase II study of CPT-11, a new derivative of camptothecin, for previously untreated non-small-cell lung cancer. [electronic resource] - Journal of clinical oncology : official journal of the American Society of Clinical Oncology Jan 1992 - 16-20 p. digital

Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't

0732-183X

10.1200/JCO.1992.10.1.16 doi


Adult
Aged
Antineoplastic Agents, Phytogenic--administration & dosage
Camptothecin--administration & dosage
Carcinoma, Non-Small-Cell Lung--drug therapy
Diarrhea--chemically induced
Drug Evaluation
Female
Humans
Infusions, Intravenous
Irinotecan
Leukopenia--chemically induced
Lung Neoplasms--drug therapy
Male
Middle Aged